BAJAJHCARE333.00

Bajaj Healthcare Limited

· Pharma & Health
₹ CrorePeersTHEMISMEDLINCOLNWANBURYSIGACHIAHCLANUHPHRAMRUTANJANMcap ₹1,121 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt332.1222.6233.5233.5
Net Debt329.9220.0196.2196.2
Total Debt/Equity1.190.480.440.44
Net Debt/Equity1.190.470.370.37
Total Debt/EBITDA4.352.702.232.23
Net Debt/EBITDA4.332.671.871.80
Interest Coverage (EBIT/Interest)1.641.953.483.48
Total Debt/Total Capital %54.4032.3230.4630.46
As Filed — company-reported covenants
Debt/Equity (as filed)0.4844.0046.00
Debt Service Coverage (as filed)0.44215.00247.34
Interest Service Coverage (as filed)3.65380.00370.21
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.